Radiopharmaceuticals
Ended Awarded Last action
- Contract number
- 36C25224N0282
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI EQ4VSLH8RC33
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $149,793
Award facts
- Contract value 26% obligated
-
- $149,792.63 Current, with exercised options
- $572,460.43 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Orlovista, FL 32811, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$67,540 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $217,332 |
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a $572,460.43 delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) on April 1, 2024, for the supply of radiopharmaceuticals. The contract, which carries a firm fixed-price structure with an ultimate completion date of March 31, 2025, will be performed in Orlovista, Florida. This delivery order was issued without a set-aside designation and represents a continuation of the VA's reliance on Jubilant Radiopharma's specialized nuclear medicine products, which include medical isotopes such as Gallium 68 Dotatate, technetium-99m, and iodine I-123 used in diagnostic imaging and cancer treatment procedures across the VA healthcare system.
Jubilant Radiopharma, a self-certified small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, has established itself as a critical supplier of radiopharmaceuticals to federal healthcare agencies. The company holds multiple indefinite delivery vehicles with the VA, including contracts valued up to $39.8 million, and regularly receives task orders from various VA regional networks to support nuclear medicine services nationwide. This delivery order falls within the company's broader portfolio of VA contracts, which typically range from approximately $30,000 to $1.7 million, demonstrating its capability to meet the sustained demand for specialized medical isotopes across the veterans healthcare network.
Quick answers
Who was awarded contract 36C25224N0282?
36C25224N0282 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on April 1, 2024.
How much is contract 36C25224N0282 worth?
The government has obligated $149,793 on 36C25224N0282. Its potential value, with all options, is $572,460.
Is contract 36C25224N0282 an order under another contract?
Yes. 36C25224N0282 is a delivery order under 36C25222D0030, an indefinite delivery contract.
Was contract 36C25224N0282 competed?
The extent of competition for 36C25224N0282 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award